Zhejiang Huakang Pharmaceutical Co Ltd (605077) — Cash Flow Reinvestment Rate
Zhejiang Huakang Pharmaceutical Co Ltd (605077) has a Cash Flow Reinvestment Rate of 20.59x as of December 2024, reinvesting CN¥3.02 Billion (capex CN¥1.43 Billion plus investments CN¥-1.59 Billion) from operating cash flow of CN¥146.50 Million. Explore 605077 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Huakang Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Zhejiang Huakang Pharmaceutical Co Ltd across 9 annual periods. Also explore total assets of Zhejiang Huakang Pharmaceutical Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Zhejiang Huakang Pharmaceutical Co Ltd (2016–2024)
Year-by-year capital reinvestment analysis for Zhejiang Huakang Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 605077 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 20.59x | CN¥3.02 Billion | CN¥146.50 Million | CN¥1.43 Billion | ▲ +554.2% |
| 2023 | 3.15x | CN¥1.95 Billion | CN¥619.47 Million | CN¥690.70 Million | ▲ +41.8% |
| 2022 | 2.22x | CN¥603.67 Million | CN¥271.98 Million | CN¥539.75 Million | ▼ -63.7% |
| 2021 | 6.11x | CN¥1.62 Billion | CN¥264.32 Million | CN¥360.93 Million | ▲ +240.8% |
| 2020 | 1.79x | CN¥601.43 Million | CN¥335.24 Million | CN¥252.95 Million | ▲ +130.9% |
| 2019 | 0.78x | CN¥218.54 Million | CN¥281.31 Million | CN¥132.21 Million | ▼ -9.8% |
| 2018 | 0.86x | CN¥121.38 Million | CN¥140.97 Million | CN¥121.38 Million | ▲ +320.6% |
| 2017 | 0.20x | CN¥16.49 Million | CN¥80.56 Million | CN¥16.49 Million | ▼ -24.8% |
| 2016 | 0.27x | CN¥25.32 Million | CN¥93.02 Million | CN¥25.32 Million | — |